Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of BIA 5-453 in Fasted vs Fed Conditions
NCT03090568Phase 1Completed
- Sponsor
- BIAL
- Start
- Jul 2008
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of etamicastat in hypertension (HTN) and heart failure (HF) (2 arms), sponsored by BIAL. Primary endpoints: Maximum Plasma Concentration at 72 hours, Time to Maximum Plasma Concentration at 72 hours and 2 more. Started Jul 2008; status: completed.
02
Drugs
etamicastat
03
Conditions
hypertension (HTN)heart failure (HF)
Beyond the preview
Go deeper on NCT03090568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090568.